A digital marker for stratifying cardiovascular metabolic comorbidities among the middle-aged and elderly adults

Danhui Mao1,2, Sheng Zhao1, Jiao Lu3

  • 1Shanxi Medical University, Taiyuan, China.

PLOS Digital Health
|July 2, 2026
PubMed

Insights

This study introduces a novel digital marker to classify Cardiovascular Metabolic Comorbidities (CMM) into risk groups. This tool integrates network analysis and machine learning for improved CMM subgroup identification and risk stratification.

Area of Science:

  • Cardiovascular and Metabolic Diseases
  • Computational Biology and Bioinformatics
  • Machine Learning in Healthcare

Background:

  • Cardiovascular Metabolic Comorbidities (CMM) share underlying mechanisms like inflammation and insulin resistance, leading to complex interactions.
  • Current methods for describing CMM status based solely on clinical features are insufficient.
  • Distinct CMM subgroups require systematic characterization for effective management.

Purpose of the Study:

  • To develop a digital marker for characterizing CMM subgroups based on cross-sectional data.
  • To systematically reveal distinct CMM subgroups using network analysis and machine learning.
  • To assess the potential of the digital marker for early detection and stratified interventions.

Main Methods:

  • Constructed a directed acyclic network for CMM using demographic, clinical laboratory, and disease data via the DirectLiNGAM algorithm.
  • Analyzed network features (in-degree, out-degree, centrality measures) to rank node importance and select key clinical parameters.
  • Evaluated ten machine learning algorithms for digital marker generation, with Ridge regression showing optimal performance.
  • Binned digital markers to classify CMM into Low, Middle, and High risk groups.

Main Results:

  • Network analysis identified key clinical parameters (e.g., GLU, HBALC, TC) and demographic factors (e.g., Male) influencing CMM.
  • Ridge regression demonstrated superior performance in predicting mortality (AUC, PR-AUC, Brier Score, Log Loss).
  • The developed digital marker effectively classified CMM into Low, Middle, and High risk groups with distinct average scores.

Conclusions:

  • A novel digital marker integrating network analysis and machine learning effectively delineates CMM subgroups.
  • This digital marker holds potential for early detection of CMM risk.
  • The findings support future research on stratified interventions for high-risk CMM groups.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...